GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (FRA:1NE) » Definitions » Float Percentage Of Total Shares Outstanding

Verrica Pharmaceuticals (FRA:1NE) Float Percentage Of Total Shares Outstanding : 44.21% (As of May. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Verrica Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Verrica Pharmaceuticals's float shares is 18.75 Mil. Verrica Pharmaceuticals's total shares outstanding is 42.42 Mil. Verrica Pharmaceuticals's float percentage of total shares outstanding is 44.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Verrica Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Verrica Pharmaceuticals's Institutional Ownership is 14.70%.

Verrica Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Verrica Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=18.75/42.42
=44.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verrica Pharmaceuticals (FRA:1NE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (FRA:1NE) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
CYDY FHTX ATNM NVCT LYRA BIVI OTLK GLUE VOR STRO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VRCA:USA 1NE:Germany
Address
44 West Gay Street, Suite 400, West Chester, PA, USA, 19380
Website
https://www.verrica.com
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals (FRA:1NE) Headlines

No Headlines